Latest News

Opsona Therapeutics appoints Chairman Dr. Bernd R. Seizinger as Executive Chairman

06 May, 2011 – DUBLIN, Ireland: Opsona Therapeutics, a drug development company focused on novel therapeutic approaches to target autoimmune and inflammatory diseases today announced that its Board of Directors has appointed Chairman Bernd Seizinger M.D., Ph.D., as Executive Chairman, following the resignation of founding CEO Mark Heffernan, Ph.D. Dr. Heffernan...

< back to home page